Canada Markets open in 3 hrs 54 mins

Small Pharma Inc. (DMTTF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1121+0.0026 (+2.38%)
At close: 03:59PM EDT

Small Pharma Inc.

6-8 Bonhill Street
3rd Floor
London EC2A 4BX
United Kingdom

Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. George TzirasCEO & Non-Independent Director288.17kN/AN/A
Mr. Peter David RandsChief Innovation & Intellectual Property Officer, Founder and Director338.95kN/AN/A
Mr. David SteelChief Financial Officer281.27kN/AN/A
Dr. Carol RoutledgeChief Scientific & Medical Officer351.9kN/AN/A
Ms. Marie Claire LayzellChief Manufacturing & Devel. Officer & Director332.47kN/AN/A
Dr. Alastair James Riddell M.D., M.Sc., MBChB, MFPM, MRCGP, MSc, Ph.D.Chief Operating OfficerN/AN/A1949
Mr. Richard M. Kimel HBA, LLBCorp. Sec.N/AN/A1967
Mr. Jim RennieDirector of Devel. and Member of Scientific & Advisory BoardN/AN/AN/A
Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. The company's clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. It is also developing a pipeline of proprietary preclinical assets. The company was founded in 2015 and is headquartered in London, the United Kingdom.

Corporate Governance

Small Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.